Antisense Pharma GmbH
- Pharmaceutical Sales 2009
-
0 EUR
- Product Range
- N/A
- Key Research Areas
- Treatments for aggressive tumors: malignant brain tumors (gliomas), advanced pancreatic cancer, malignant melanoma and advanced colorectal cancer
- R&D Expenditure 2008
-
worldwide: 13,596,344 US Dollar
in Germany: 10,071,366 EUR
- Employees in the Pharmaceuticals Division 2009
-
in Germany (and worldwide): 70
(All data based on corporate information, as of: 05/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page